Abirasteron Tablet 120 is primarily utilised for managing metastatic castration-resistant prostate cancer (mCRPC) in adult men. This medicine is known as an androgen biosynthesis inhibitor.
In addition to its primary use, this medicine has the ability to slow down the proliferation of prostate cancer cells. This is particularly beneficial in mCRPC, a severe form of prostate cancer, which keeps spreading despite treatments aimed at lowering testosterone levels.
Before commencing this medicine, consult your doctor, who will advise you on the right dosage and frequency. Inform your doctor of any pre-existing conditions or ongoing medications. If you notice any side effects while on this medication, notify your doctor immediately. It is crucial to continue the medicine for the duration prescribed by your doctor to achieve optimal results.